EZZ ASX · Health Care

EZZ Life Science Holdings Ltd

Announcements, last 12 months
26
Price sensitive, last 12 months
9
Followed on InvestorPA
Some (Among the 20% most-followed companies on InvestorPA)

Latest announcements

Released Headline Actions
Change of Director's Interest Notice
EZZ Corporate Governance Statement and Appendix 4G
Annual Report to shareholders
Preliminary Final Report Price sensitive AI summary
Quarterly Activity and Cashflow Report Price sensitive AI summary
Quarterly Activity and Cashflow Report Price sensitive AI summary
Half Yearly Report and Accounts Price sensitive AI summary
EZZ Appoints Aumake in $10m Exclusive Distributor Agreement Price sensitive AI summary
$10m Exclusive Distribution Agreement with EZZ Life Sciences Price sensitive AI summary
Quarterly Activities/Appendix 4C Cashflow Report Price sensitive AI summary

Sign in to see all EZZ announcements.

Guidance history

31 Jul 2026 Customer receipts $9.8m, operating cash outflow $0.05m, cash and cash equivalents $9.7m
17 Feb 2026 The agreement sets out minimum sales targets of $2.5m per year each year for four years, totaling $10 million Australian dollars for the product range.
30 Oct 2025 The company expects higher sales in Q2 ahead of the 11.11 Shopping Festival.

Sign in to see the full guidance history.

Most followed in Health Care

  • PME Pro Medicus Ltd
  • AHC Austco Healthcare Ltd
  • CSL CSL Ltd
  • RMD Resmed Inc
  • TLX TELIX Pharmaceuticals Ltd
  • CGS Cogstate Ltd
  • ALC Alcidion Group Ltd
  • CSX Cleanspace Holdings Ltd
Follow EZZ to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in